Melinda Hsu, MD
Specialty
Hematology and Oncology, Medical Oncology
Accepting New Patients
Videos
Watch to find out more about this University Hospitals provider.
Languages Spoken
English
Office Locations
Patient Experience Reviews
4.9 out of 5
42 Ratings
Patient Comments (9)
Reviewed On 8/1/2023
Dr. Hsu is exceptional in assessing my current health status and the effects of medications on my health status. Involves me and my husband in the plan of care. Excellent patient/ family interaction and concern for my safety.
Reviewed On 7/1/2023
Dr. Hsu made me feel like I was the only patient she had for the day. I was not rushed and was given all the time I needed with the doctor. I was treated with kindness and respect.
Reviewed On 6/1/2023
Dr Hsu was extremely helpful and informative.
Reviewed On 6/1/2023
Very professional
Reviewed On 4/1/2023
All good. No complaints.
Reviewed On 3/1/2023
Dr Hsu is very reassuring . She's very positive. She is very caring and kind.
Reviewed On 3/1/2023
I was very impressed with Dr. Hsu's knowledge and the way she spoke with me. She put me more at ease than I thought I could possibly be.
Reviewed On 2/1/2023
Dr Hsu is a great listener making it easy for her to address my concerns and puts me at ease during these difficult times.
Reviewed On 2/1/2023
Good always helpful will always be a patient there
Certifications & Memberships
- Internal Medicine - American Board of Internal Medicine
Education
Fellowship | Medical Oncology
Medical Oncology - Johns Hopkins Hospital (2018 - 2021)
Residency | Internal Medicine/Chief Resident
Internal Medicine/Chief Resident - Indiana University Hospital (2017 - 2018)
Residency | Internal Medicine
Internal Medicine - Indiana University Hospital (2014 - 2017)
Medical Education
University Of Cincinnati College Of Medicine (2014)
Other Education
Georgetown University (2006)
Undergraduate
Harvard University (2005)
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Melinda Hsu did not disclose any Outside Relationships with Industry.